Water treatment plants and pharmaceutical residues in Catalonia and Italy by Petrovic, Mira & Verlicchi, Paola
Water treatment plants and 
pharmaceutical residues in 
Catalonia and Italy 
Mira Petrovic,1,2 Paola Verlicchi3,4* 
1Catalan Institute for Water Research (ICRA), Technological Park of the University of 
Girona, Girona, Catalonia. 2Institució Catalana de Recerca i Estudis Avançats (ICREA), 
Barcelona, Catalonia. 3Department of Engineering, University of Ferrara, Ferrara, Italy. 
4Terra&Acqua Tech Technopole of the University of Ferrara, Ferrara, Italy
 
Summary. This study analyses the occurrence of commonly administered pharma-
ceuticals in urban and treated wastewater and surface waters in Catalonia and Italy, 
reviewing recently published investigations. The reported removal efficiencies in 
common municipal wastewater treatment plants are also discussed and pharmaceu-
tical load discharged after these treatments are analysed. Finally, environmental risk 
posed by the presence of some of these compounds in surface water is discussed, and 
a case study highlighting the issue of pharmaceutical residues in the environment is 
presented. [Contrib Sci 10:135-150 (2014)]
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Introduction
Over the last 15 years, as the annual consumption of phar-
maceutical compounds (PhCs) has increased worldwide, in-
creasing attention has been focused on their presence in dif-
ferent aquatic environments in many countries. Antibiotics, 
analgesics and anti-inflammatories, beta-blockers, lipid regu-
lators, beta-agonists, hormones, antineoplastics, and iodin-
ated contrast media (ICM) are some of the most commonly 
administered therapeutic and diagnosis classes of drugs. 
Consequently, they are the ones most often studied by re-
searchers.  
After administration, the active substances of medica-
tions are metabolized by the body, but only to a certain ex-
tent. The unmetabolized portion is excreted, largely in the 
urine and to a lesser extent in the faeces, unchanged, as a 
mixture of metabolites; alternatively, they may be conjugat-
ed by the attachment of an inactivating compound. This 
makes sewage and treated wastewater by far the greatest 
source of human PhCs that reach the surface water, whether 
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after excretion or through inappropriate disposal. Additional 
sources of residues of active compounds in the environment 
are effluents from livestock farms (e.g., PhCs such as tylosin, 
oleandomycin and spiramycin are used as animal growth pro-
moters) and wastewater from the pharmaceutical industry.
The pharmaceuticals detected with high frequencies in 
surface water are generally those administered in greater 
quantities, but many exceptions occur. In fact, some 
compounds (e.g., the antibiotic amoxicillin) are consumed 
in large amounts but are not detected in the environment 
because of their rapid degradation. Conversely, drugs used 
in smaller quantities (e.g., the psychiatric drug and anti-
epileptic carbamazepine and the lipid regulator clofibric acid) 
are found in relatively high concentrations in receiving water 
bodies. The concentrations of PhCs in wastewater and treated 
effluent, i.e., the effluent from wastewater treatment plants 
(WWTPs), generally range from several ng/l to hundreds of 
µg/l, with few exceptions. This has led to these contaminants 
being described as “micro-pollutants.”
The difficulties in the detection and monitoring of micro-
pollutants are mainly due to the sophisticated analytical 
techniques and instrumentation required, the time-
consuming methodologies and the high costs involved. One 
of the first PhC monitoring campaigns in Italy was carried out 
by researchers from the Milan Istituto Mario Negri, in 2000 
[34]. In that work, “major environmental contaminants” 
were identified for the first time, based on their consumption 
and theoretical loads, ubiquity in surface water, persistence 
and toxicity, after which methods to measure these 
compounds in the environment were devised. The selected 
PhCs were detected in many of the samples obtained from 
surface water (Po, Lambro and Adda rivers), river sediments, 
and waterworks in Milan, Varese and Lodi. In the years 
that followed, other Italian research groups carried out 
investigations on different aquatic environments: rivers and 
lakes, WWTP influents and effluents, hospital effluents, 
groundwater and tap water. The aims of those studies were: 
to (i) evaluate the occurrence of common PhCs; (ii) analyze 
the removal efficiencies of common WWTPs; (iii) suggest 
the best treatment sequence and operational conditions 
for optimal removal, and (iv) assess the environmental risk 
posed by the presence of PhC residues.
Within this framework, in this article we describe the 
occurrence of common PhCs in different water environments 
in both Italy and Catalonia and report the removal 
efficiencies achieved for most compounds in municipal 
WWTPs recently investigated in these areas. We also discuss 
the potential environmental risks posed by the presence 
of these compounds in surface water. Finally, we present 
a case study that highlights the findings to date. Note that 
current legislation in neither Italy nor Catalonia includes 
WWTP effluent limits for PhC concentrations (µg/l) or loads 
(g/year), although the health authorities in both countries 
are carrying out investigations aimed at identifying the most 
critical (target) compounds.
Investigation areas: Catalonia and Italy
Catalonia. The results reported here are taken from 
several previously published studies on the occurrence and 
distribution of PhCs in several Catalonian WWTPs, mainly 
in the Llobregat River basin (Fig. 1) and in the Barcelona 
metropolitan areas treating urban wastewaters from the city 
of Barcelona. The other investigated Catalonian WWTPs are 
situated in Girona and in the Ebro River basin and treat urban 
wastewater from Lleida and Tortosa. We have also included 
the results of several studies reporting PhC levels in other 
Catalonian WWTPs, but due to confidentiality agreements 
they must remain anonymous. 
Italy. The main Italian investigations described herein were 
carried out in: surface waters, including (i) the Po, Adda, 
Lambro, Olona and Arno Rivers; (ii) Lake Maggiore and some 
of its tributaries, Lakes Vico and Bracciano; (iii) canals in the 
Po Valley surface water network, which are generally used for 
irrigation needs from May to October; (iv) the raw influent 
and treated effluents from 10 municipal WWTPs, mostly 
in northern Italy; (v) rivers and their sediments, and (vi) 
effluents from hospital of different sizes (number of beds).
The map in Fig. 2 shows most of the sampling sites. In some 
investigations, the confidential nature of the information 
provided prevented us from identifying the precise sites of 
the experimental campaigns. 
The behaviour of PhCs in different 
aquatic environments
PhCs comprise a wide spectrum of highly active substances 
designed to interact with biological receptors in humans and 
animals. They are generally grouped into therapeutic classes 
according to their physiological activity. However, these com-
pounds, even if they belong to the same therapeutic class, 
may have very different chemical structures and phy sico-
chemical properties, resulting in very different behaviors dur-
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ing wastewater treatment. Moreover, many PhCs, including 
erythromycin, cyclophosphamide, naproxen and sulfa-
methoxazole, can persist in the environment for a year or 
more. Clofibric acid, for example, a metabolite of clofibrate, 
has an estimated environmental persistence of 21 years and 
is still detectable in lakes and rivers although the parent com-
pound was withdrawn from the market long ago.
The complex behaviour of pharmaceuticals in the sewage 
network and during subsequent wastewater treatment cor-
relates with the nature of their molecular structure, which 
may contain concomitant acidic and basic functional groups, 
as in the case of ciprofloxacin. These molecules may therefore 
be considered as neutral, cationic, anionic or zwitterionic, ac-
cording to the particular environmental conditions, which will 
consequently affect their behaviour. Hence, a working knowl-
edge of the physicochemical properties of PhCs allows a 
(rough) prediction of the processes occurring during their 
passage through WWTPs. These processes may involve sorp-
tion onto solids, biodegradation or chemical transformation. 
After their discharge into a surface water body, residual PhCs 
may be subjected to photolysis and photodegradation, which 
may reduce their environmental impact [18].
The PhCs monitored in the experimental campaigns de-
scribed in this article were generally selected according to 
the following criteria: high consumption in the study area, 
widespread occurrence in raw urban wastewater and treated 
effluent throughout the world, and the availability of analyti-
cal methods. They mainly comprised members of the follow-
ing therapeutic classes: analgesics and anti-inflammatories, 
antibiotics, antidiabetics, anti-hypertensives, beta-blockers, 
diuretics, lipid regulators, psychiatric drugs, receptor antago-
nists, hormones, beta-agonists, anti neo plastics, topical prod-
ucts, antiseptics, and contrast agents. However, it is very dif-
ficult to obtain data pertaining to national or regional con-
sumption of these compounds, as figures generally refer only 
to the sales of each active compound or therapeutic class.
Common municipal wastewater treat-
ment plants
Domestic (also known as urban) wastewaters are generally 
subjected to a treatment sequence consisting of preliminary 
treatments (screening, grit removal, oil and grease removal), 
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Fig. 1. Map showing the location of the Llobregat 
River basin in Catalonia, and several of the WWTPs 
investigated.
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a primary gravity settling step (this step is sometimes omitted), 
secondary biological treatment (usually activated sludge sys-
tems) and tertiary treatments, sometimes including advanced 
methods (chemical coagulation, flocculation, sedimentation, 
activated carbon filtration, disinfection and/or chemical oxi-
dation). The scheme in Fig. 3 shows the sequences generally 
adopted for raw wastewater and the resulting sludge, as well 
as the main routes by which pharmaceuticals originally in-
tended for human use are released into the environment. 
Activated sludge treatment is the most extensively em-
ployed secondary step in the processing of both urban waste-
waters from small and large communities and industrial ef-
fluents. It consists mainly of flocculating microorganisms held 
in suspension and contact with wastewater in a mixed aerat-
ed tank. The so-called conventional activated sludge system 
consists of a biological reactor (where the activated sludge 
may develop and grow) followed by a secondary clarifier.
The biological reactor may consist of one or more com-
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Fig. 2. Map of Italy showing the locations of most of the investigated WWTPs (left), and a map of the most-investigated area, including the surface 
water sampling points (right).
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Fig. 3. Main PhC contamination routes in the water cycle and the sequence usually adopted for the treatment of domestic wastewaters.
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partments (Fig. 3). Multiple compartments provide different 
operational conditions, namely aerobic and anaerobic, and 
thereby enable the removal of C, N and P. The main physical 
and biochemical processes occurring within the activated 
sludge process are adsorption, absorption, flocculation, oxi-
dation, reduction and sedimentation. Degradation of the or-
ganic compounds in the influent wastewater by the biological 
reactor is mainly brought about by biochemical reactions 
(anabolic, catabolic and co-metabolic reactions), performed 
by the microorganisms suspended in the liquid, which flour-
ish as these reactions take place. Organic compounds subject 
to biodegradation include not only lipids, proteins and carbo-
hydrates, which are present in concentrations of the order of 
mg/l, but also micro-pollutants (i.e., pharmaceuticals and 
personal care products), which are generally detected at ng/l 
or µg/l concentrations.
After enough time for the appropriate biochemical reac-
tions has elapsed, the mixed liquor is transferred to a settling 
tank (secondary clarifier) to allow gravity separation of the 
suspended solids (in the form of floc particles) from the 
treated effluent. Some of the settled solids are returned to 
the biological reactor (return activated sludge) in order to 
maintain its desired biomass concentration (about 3–4 g/l), 
and the remainder, considered as waste (so-called excess 
sludge), is subjected to thickening by the removal of a por-
tion of the liquid fraction in order to increase the solid con-
tent. Through the processes of stabilization, dewatering, dry-
ing and combustion, both the water and organic fractions are 
considerably reduced, and the processed solids (treated or 
digested sludge) are then suitable for reuse or disposal.
Occurrence in different aquatic envi-
ronments
The following figures report WWTP influent and effluent con-
centrations of common PhCs in the investigated full-scale 
plants in Catalonia and Italy. Compounds are reported in de-
scending order of concentration detected in the water. Gen-
erally, the analysis refers to 24-hour composite water sam-
ples in order to provide a concentration representative of the 
sampling day.
WWTP influents in Italy and Catalonia
The concentration ranges of common PhCs reported in the raw 
influent to 10 Italian municipal WWTPs are shown in Fig. 4A, 
and the detected levels in influent waters to nine WWTPs in 
Catalonia are presented in Fig. 4B. In Italy, the compound with 
the highest maximum concentration was the anti-inflamma-
tory ibuprofen (about 10 µg/l), followed by the analgesics/
anti-inflammatories diclofenac, naproxen, acetaminophen 
and mefenamic acid, the antibiotics ciprofloxacin and ofloxa-
cin, the beta-blocker atenolol, the anti-hypertensive hydro-
chlorothiazide, and the psychiatric drug carbamazepine. Ibu-
profen, hydrochlorothiazide and atenolol were always detect-
ed at concentrations >1 µg/l.
This finding is consistent with the fact that most of these 
compounds are consumed for prolonged periods, and in some 
cases year round (in particular atenolol, hydrochlorothiazide 
and carbamazepine). The maximum concentrations of 25 of 
the other investigated compounds were between 100 and 
950 ng/l, and those of the remaining 24 were between 1 and 
99 ng/l. In another full-scale WWTP (data not shown), the raw 
influent concentrations of PhCs were significantly lower than 
those reported in Fig. 4A. In a study of 42 selected PhCs at this 
plant, all displayed influent concentrations <0.7 µg/l [15]. 
However, this was reportedly due to their dilution by infiltra-
tion of groundwater into the sewer system. 
In Catalonia, non-steroidal anti-inflammatory drugs 
(NSAIDs) had the highest influent concentrations at the inves-
tigated WWTPs, as was expected due to their high level of con-
sumption. Naproxen, ketoprofen and diclofenac were detect-
ed in all the samples at concentrations above the µg/l level.
Typically, this group of drugs accounted for roughly 65% 
of all the therapeutic agents analyzed in the influents. Lower, 
but still significant, concentrations of lipid-modifying agents 
(including fibrates and statins), antibiotics (ciprofloxacin, 
ofloxacin), diuretics (hydrochlorothiazide) and beta-blockers 
(atenolol) were also detected in the Catalonian WWTP influ-
ents. Other compounds typically present at high concentra-
tions were carbamazepine, glibenclamide and sulfonamide 
antibiotics. A further 25 compounds were detected at levels 
reaching the range of 100–900 ng/l.
WWTP effluents in Italy and Catalonia
The concentration ranges of the investigated compounds in 
the secondary effluents of full-scale conventional municipal 
WWTPs in Italy are shown in Fig. 5A. The compounds are re-
ported according to their descending order of concentration. 
The highest concentrations detected were 5.5 µg/l (diclofe-
nac), 5.22 µg/l (naproxen) and 4.76 µg/l (gemfibrozil, a lipid 
regulator). For another six compounds, namely the diuretic 
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furosemide, the anti-hypertensive hydrochlorothiazide, the 
psychiatric drug carbamazepine, the beta-blocker atenolol, 
and the antibiotics ciprofloxacin and ofloxacin, the maximum 
values were >1 µg/l. The maximum concentrations of 28 oth-
er investigated compounds were between 100 and 950 ng/l, 
17 were between 1 and 99 ng/l, and seven <1 ng/l. The anal-
gesics ibuprofen (0.18 µg/l) and acetaminophen (0.058 µg/l), 
detected at the highest concentrations in the WWTP influent, 
thus belonged to the second and third groups, respectively, 
in the secondary effluent. 
In the Catalonian WWTP effluents, the compounds found 
at the highest concentrations were iodinated X-ray contrast 
agent (iopromide), followed by the diuretics hydrochlorothi-
azide and furosemide, the NSAIDs ibuprofen and diclofenac, 
A
B
Fig. 4. (A) Concentration ranges of common PhCs in the raw influents of Italian municipal WWTPs. Data from [3,8,22,26,35,36]. (B) Concentration ranges of 
common PhCs in the raw influents of municipal WWTPs in Catalonia. Data from [11,15,16,23].
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the lipid regulator gemfibrozil, and the histamine H2-recep-
tor antagonist ranitidine (Fig. 5B). However, the concentra-
tions detected varied substantially, depending on the remov-
al efficiency of the WWTP and/or the physicochemical prop-
erties of the compounds in question. Overall, the compounds 
detected and their concentrations were very similar to those 
found in Italian WWTPs. 
Observed removal efficiencies in con-
ventional municipal WWTPs
The removal efficiencies from the liquid phase evaluated in 
five Italian WWTPs and six Catalonian WWTPs treating do-
mestic wastewater are reported in Fig. 6A according to the 
schematic in Fig. 1. The removal efficiency for each PhC may 
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Fig. 5. (A) Concentration ranges of common PhCs in the effluents of Italian municipal WWTPs. Data from [1,2,3,6,22,26,35,36]. (B) Concentration ranges for 
common PhCs in the effluents of municipal WWTPs in Catalonia. Data from [11,15,16,23].
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vary over a wide range due to many factors affecting the dif-
ferent removal mechanisms that occur within the WWTP, 
namely biodegradation, adsorption onto sludge and chemi-
cal reactions, as discussed in [27]. 
The most important factors affecting removal efficiency 
are related to operational conditions (mainly hydraulic reten-
tion time, sludge retention time, pH, redox conditions, bio-
mass concentration in the aeration tank), environmental con-
ditions (mainly temperature) and biological reactor configu-
rations (number and shape of the compartments and feeding 
mode). In addition, the removal efficiencies in summer and 
winter may differ. 
According to Castiglioni et al. [7], PhCs can be grossly di-
vided into three groups: those with higher removal efficien-
cies in summer than in winter, which include amoxicillin (me-
dian about 75% in winter and 10% in summer), atenolol (10% 
and 55%), bezafibrate (15% and 87%), enalapril (18% and 
100%), furosemide (8% and 54 %), ibuprofen (38% and 93%), 
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Fig. 6. (A) Variability of the removal efficiencies for common PhCs in full-scale Italian WWTPs. Data from [5,6,31,35,36]. (B) Variability of the removal 
efficiencies for common PhCs in full-scale Catalonian WWTPs. Data from [11,15,16,23].
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ranitidine (39% and 84%) and sulfamethoxazole (17% and 
71%); those with fairly uniform removal over the course of 
the year, including ciprofloxacin (60%), hydrochlorothiazide 
(30%) and ofloxacin (50%); and a third group with negligible 
removal in both seasons (carbamazepine, clarithromycin, 
erythromycin, lincomycin, salbutamol, spiramycin and es-
trone). In general, the removal efficiencies for the different 
compounds are higher under aerobic than anaerobic condi-
tions in the biological reactor.
The PhC removal achieved in conventional municipal 
WWTPs that feature activated sludge as secondary treatment 
is illustrated in Fig. 6. In many WWTPs a final disinfection step 
consists of the addition of sodium hypochlorite (NaClO), but 
its overall effect on PhC removal is quite modest. Zuccato et 
al. [36] found that the effect of NaClO addition varies depend-
ing on the compound, greatly improving the removal of raniti-
dine, diazepam and hydrochlorothiazide, but only modestly 
improving that of ciprofloxacin, vancomycin, ofloxacin, furo-
semide and lincomycin, and having little effect on the overall 
removal of salbutamol, atenolol, atorvastatin and bezafibrate.
Occasionally, negative removal efficiencies have been re-
ported. While for some compounds this phenomenon is 
clearly ascribable either to the presence of deconjugates that 
interfere with biological transformation of the deconjugated 
compounds or to the release of PhC sorbed onto the particu-
late matter and dissolving after biological treatment, for oth-
ers mechanism is unknown and requires investigation. How-
ever, note that at the low level of concentrations of some 
PhCs detected in the influent and secondary effluent, instru-
mentation errors may lead to their apparent release during 
their passage through the treatment plant.
Polishing treatments can further reduce the residual PhC 
content in final effluents. As suggested by Verlicchi et al. [31], 
in small communities in particular, a final treatment by means 
of constructed wetlands (horizontal subsurface flow beds) 
can be useful to this effect.
The data reported in Fig. 6A and 6B only pertain to the 
water phase, and thus PhC occurrence only in the influent 
and the effluent. However, as some compounds may be re-
moved by sorption onto sludge, the calculation of the overall 
 
Table 1. Fraction discharged with the effluent, sorbed onto sludge and removed during treatment. 
Modified from [15]
Compounds Effluent (%) Sorbed onto sludge (%) Removed (%)
Ketoprofen 21 79
Naproxen 13 83 
Diclofenac 64 1 35
Bezafibrate 27 73 
Gemfibrozil 39 61
Atorvastatin 42 2 56
Lorazepam 48 3 49
Carbamazepine 73 2.5 24.5
Ranitidine 12 88
Trimethoprim 40 60
Metronidazole 20 80
Clarithromycin 48.5 3 48.5
Azithromycin 56 44
Atenolol 40 60
Sotalol 56 44
Salbutamol 31 69
Furosemide 24 2 66
Hydrochlorothiazide 55 1.5 43.5
Enalapril 6 94
Glibenclamide 24 4 72
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removal efficiency of a WWTP has to take into account also 
the solid phase. Nonetheless, very few investigations have at-
tempted to evaluate PhC occurrence in sludge. Indeed, in Ita-
ly, only Jelic et al. [15] analyzed sludge samples, evaluating 
the fraction (with respect to the influent load) discharged 
with the liquid effluent, sorbed onto sludge and removed 
during treatment. Their results (Table 1) clearly show that the 
quantity of the selected compounds removed by sorption is 
generally quite modest. 
PhC loads
To evaluate the impact of a treated effluent in a surface wa-
ter body, daily average loads are considered. In this study, 
these were generally lower in treated water than in untreat-
ed wastewater, with some exceptions. Indeed, in some cas-
es, spiramycin and erythromycin were more abundant in ef-
fluents than in influents, as they can bind to particles and 
suspended solids from which they are later released.
Table 2 lists the minimum and maximum loads of com-
monly administered PhCs, expressed as mg/day/1000 in-
habitants, reported for the investigated Italian WWTPs (of 
different nominal sizes) employing the treatment sequence 
shown in Fig. 1. 
Castiglioni et al. [7] compared the winter and summer 
loads of the Varese Olona WWTP. They monitored eight 
common pharmaceuticals belonging to five therapeutic 
classes. The differences in the concentrations of these drugs 
were not statistically significant: in particular, loads of ateno-
lol, furosemide, hydrochlorothiazide and ranitidine were 
comparable in the two seasons, while for ibuprofen, cipro-
floxacin, ofloxacin and sulfamethoxazole the loads were 
higher in summer than in winter. This result is consistent 
with the consumption pattern, which remains constant 
throughout the year for beta-blockers (atenolol), diuretics 
(furosemide and hydrochlorothiazide) and antiulcer drugs 
(ranitidine), but features seasonal peaks in winter for antibi-
otics (ciprofloxacin, ofloxacin and sulfamethoxazole) and 
anti-inflammatories (ibuprofen).
Surface water
Researchers in Italy have investigated various aquatic envi-
ronments: major rivers (the Po in north and the Arno in cen-
tral Italy); tributaries (Adda, Lambro and Olona) [4,34–36]; 
surface water network canals [1,23]; mountain rivers; Lake 
Maggiore [19], and drinking (tap) water [9,19,34]. Rivers 
were investigated at different sampling points along their 
course, downstream of both the inlets of the main influents 
and of the major towns. Data are reported in Fig. 7A. The 
right-hand panel of Fig. 2 shows the main sites investigated 
by the different experimental campaigns; the different sym-
bols indicate the different investigations.
Po River. The Po is the longest river in Italy (652 km), run-
ning from the western Alps to the Adriatic Sea. It collects 
wastewater from a catchment area of about 71,000 km2 in 
the most densely populated and industrialized region of Ita-
ly (about 18 million inhabitants) and sewage from about half 
of all the livestock farms in Italy. The average and maximum 
flow rates at Pontelagoscuro (Ferrara, 50 km from the Adri-
atic Sea) are, respectively, 1500 and 10,300 m3/s. All the ma-
jor towns and livestock farms along the Po are equipped 
with secondary WWTPs.
Arno River. The Arno is the fifth largest river in Italy. It 
flows through Tuscany (central Italy) and out into the Tyr-
rhenian Sea. It is 241 km long and its catchment area is 8247 
km2. The Arno River is fast-flowing due to the nature of the 
land along which its waters flow (marlstone and impervious 
clay, with the exception of a short stretch of its tributary, the 
Elsa), and the average amount of water that flows through 
its outlet to the sea varies greatly (between 6 and >2200 
m3/s).
Despite their very different characteristics, PhC concen-
trations generally increased from source to mouth in both 
rivers, exhibiting peaks corresponding to input from the 
main cities along their length (Turin, Piacenza, Cremona, 
Parma). This is particularly evident in the case of antibiotics 
[4,35], due to the high load of these pollutants entering the 
surface water along with the treated effluent from municipal 
WWTPs. The most abundant compounds in the Po River 
were ciprofloxacin, lincomycin and vancomycin, whose aver-
age concentrations ranged from 5 to 10 ng/l. In the Arno 
River, the highest average concentrations were those of cip-
rofloxacin and clarithromycin, at about 20 ng/l.
The monitoring campaign conducted by Calamari et al. 
[4] showed that pollutant loads from Milan, carried by a 
tributary (Lambro River), contribute little to the contamina-
tion of the Po River, presumably due to the comparatively 
lower flow rate and load of the Lambro (mean flow rate 
equal to 5 m3/s) than of the Po (about 1000 m3/s at the mix-
ing zone with the Lambro River).
Results from the same study by Calamari et al. [4] pro-
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vide several insights into the concentrations of veterinary vs. 
human pharmaceuticals. These authors found that the for-
mer were invariably lower, albeit with the exceptions of sal-
butamol, detected at Cremona, Casalmaggiore and Pieve in 
concentrations of 1.3–1.9 mg/l, and lincomycin. Salbutamol 
is used as bronchodilator in humans, but is also a popular, 
albeit illegal, anabolic agent for animals. The large amount 
of this drug detected in areas with a high density of livestock 
Table 2. Minimum and maximum daily loads of the investigated compounds in Italian and Catalonian full-scale WWTP 
effluents. The data are expressed in mg/day/1000 inhabitants
Italy Catalonia
Class Compound Min. Max. Min. Max.
Analgesics/Anti-inflammatories Diclofenac 82 181 24 140
Ibuprofen ND 162 33 153
Indomethacin ND 28 ND 35
Ketoprofen 5.6 93 2 94
Mefenamic acid ND 191 ND 13
Naproxen ND 68 5.7 347
Propyphenazone ND 12 4 23
Antibiotics Azithromycin 15.2 47.7 5.6 7.9
Ciprofloxacin 8.5 271 3.5 256
Clarithromycin ND 500 1.6 11
Erythromycin ND 161 9 17
Lincomycin 0.5 183 ND 14
Metronidazole 5.3 49 0.08 28
Ofloxacin 4.9 268 ND 65
Roxithromycin ND 8 ND 5,4
Spiramycin 9 418 – –
Sulfamethoxazole ND 304 11 22
Trimethoprim ND 27 4 25
Antidiabetics Glibenclamide ND 16 1 6,1
Antihypertensives Enalapril ND 58 0,05 21
Hydrochlorothiazide 50 745 21 345
Beta-blockers Atenolol 38.1 966 122 126
Metoprolol 52 63.4 ND 18
Sotalol 33 93 12 29
Timolol 1.8 3.3 ND 0.8
Diuretics Furosemide 4.9 644 11 122
Lipid regulators Bezafibrate ND 79 1 74
Clofibric acid ND 18 ND 2
Gemfibrozil 19 31 134 465
Psychiatric drugs Carbamazepine ND 422 15 122
Diazepam ND 2.3 0.06 0.8
Lorazepam 15.7 34 1.5 18
Receptor antagonists Ranitidine 6.7 266 3.5 56
Hormones Estrone ND 20 – –
Beta-agonists Salbutamol 2 8 0.3 2.1
Antineoplastics Cyclophosphamide ND 1 – –
ND: non determinated.
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farming would appear to indicate a considerable contribu-
tion resulting from its illegal use, particularly as higher doses 
are needed to trigger anabolic activity than the bronchodila-
tor effect. The high concentrations of lincomycin in the same 
area, despite a drop in its sales for human consumption, 
strongly suggest that it too is being used extensively in vet-
erinary medicine.
Comparing the loads of antibiotics detected at various dis-
tances from the sources of the two rivers, Zuccato et al. [35] 
found that, in the Po River (flow rate of 600–1000 m3/s), these 
totalled roughly 1.2 kg/day at about 200–300 km, 5.8 kg/day 
at 380 km and 4.2 kg/day at about 400 km. In the Arno River 
(average flow rate of 10 m3/s), total loads increased substan-
tially from source to mouth, reaching around 130 g/day, con-
siderably lower than in the Po. Based on data collected by 
Zuccato et al. [35], the most abundant antibiotics detected in 
the Arno River were ciprofloxacin, clarithromycin and erythro-
mycin (average concentration 20 ng/l). Veterinary antibiotics 
were generally undetectable.
Loos et al. [19] investigated the occurrence of several 
common PhCs in other natural aquatic environments in 
Northern Italy, namely Lake Maggiore (Varese), rivers and 
mountain rivers, as well as in the tap water sourced from the 
lake. Lake Maggiore receives municipal, agricultural and in-
dustrial discharges, both directly and via its tributary rivers. 
Carbamazepine, gemfibrozil and bezafibrate were detected at 
almost the same concentrations in the tap water as in Lake 
Maggiore water, indicating that they are poorly removed by 
the sand filtration and chlorination used in the Lake Maggiore 
waterworks that produce some of the local drinking water. In 
the tap water produced from groundwater, lower levels of 
these substances were detected. The levels of bezafibrate de-
tected in Lake Maggiore were in the same range as those 
found in rainwater samples collected nearby, specifically at 
concentrations up to 0.0008 µg/l.
Al Aukidy et al. [1], who compared the dilution effect in 
two case studies in which the dilution factors (corresponding 
to the ratio between the river flow rate and the WWTP efflu-
ent flow rate) differed, specifically 91 and 1, found that the 
concentrations of PhCs downstream of the point of treated 
effluent emission correlated strictly with the dilution in the 
mixing zone between the discharged effluent and the receiv-
ing water body. They determined that the hydrodynamic 
characteristics of the receiving water body thereby contrib-
uted to mitigating the risks posed by the presence of toxic 
compounds. The dilution capacity can therefore be consid-
ered of prime importance in reducing and controlling the 
toxicological effects of PhCs released into the environment.
Moreover, further degradation of residual PhCs can still 
occur in surface water bodies once the treated effluent 
leaves the WWTP. In fact, as mentioned above, if a substance 
is light-sensitive, photodecomposition may contribute to its 
further removal once in the environment. Phototransforma-
tion readily occurs in clear surface water, with the effective-
ness of this process strictly correlating with the intensity and 
frequency of available light [2,18]. Nonetheless, this process 
may be affected by other variables, specifically pH, water 
hardness, location, season and latitude [17,33].
With regard to river sediments, among the investigated 
pharmaceuticals, some have also been detected in the river 
sediments examined in Italy, in particular erythromycin (400–
630 ng/kg in the Lambro and Po rivers), ibuprofen (220 ng/kg 
in Lambro River), ranitidine (150–410 ng/kg in the Lambro 
and Po rivers), spiramycin (380–2900 ng/kg in the Lambro, Po 
and Adda rivers) and tylosin (130–2640 ng/kg in the Lambro 
and Po Rivers).
In Catalonia, the Llobregat River is a typical Mediterra-
nean river, with a fluctuating flow and under severe pres-
sure due to the industrial and agricultural activities as well 
as the dense population that characterize the region. In the 
Llobregat River basin (NE Spain) the mean annual precipita-
tion is 3330 Hm3 and the annual average discharge is 
693  Hm3. The average monthly flow registered since the 
year 2000 shows peaks of roughly 100 m3/s and minimum 
values of 1 m3/s (relative standard error: 124%). In addition, 
the Llobregat River receives the effluents discharged from 
more than 55 WWTPs; these effluents may contribute al-
most 100% of the total flow in some segments of the river, 
especially in periods of drought. Accordingly, high levels of 
organic contaminants are detectable along the river, in ris-
ing concentrations downstream of WWTPs and populated 
settlements.
In all monitoring studies to date, the PhCs detected in the 
Llobregat River closely match those identified by the Spanish 
National Health System as those most consumed. However, 
their concentrations vary widely, depending on the sampling 
time and hydrological conditions (water flow and conse-
quently dilution factor).
Generally, the NSAIDs ibuprofen, ketoprofen acetamino-
phen and diclofenac; the lipid regulator gemfibrozil; beta-
blockers atenolol, metoprolol and sotalol; the antibiotic tri-
methroprim, and the psychiatric drugs lorazepam and car-
bamazepine were the compounds detected at the highest 
concentrations in the Llobregat River. The concentrations in 
most of the samples analyzed were in the range of 10–300 
ng/l (Fig. 7B) and the contamination load increased down-
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stream along the river. However, in some hot spots, such as 
the Rubí Creek and a canal receiving overspill from the most 
contaminated fractions of the river, the levels were occa-
sionally much higher. For example, in their study of the oc-
currence of 28 multi-class pharmaceuticals in this area, 
López-Rold�n et al. [20] detected the highest concentra-
tions for the β-blockers metoprolol (8042 ng/l) and sotalol 
(788 ng/l), the antibiotic ofloxacin (1904 ng/l) and the lipid 
regulator gemfibrozil (1014 ng/l) at two sites (a canal re-
ceiving waters from the Anoia River and the Sant Feliu 
WWTP and Rubí Creek). However, the waters of these bod-
ies have been diverted so that they reach the river at loca-
tions close to its mouth, downstream of the Sant Joan Despí 
WWTP inlet, to protect the quality of the source water. 
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Fig. 7. (A) Variability in the PhC concentration ranges in Italian surface waters. (B) Concentration ranges (ng/l) of some of the most representative PhCs 
measured in the Llobregat River at Sant Joan Despí (Barcelona). 
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García-Gal�n et al. [10] also investigated the Llobregat River 
focusing on the occurrence of sulfonamide antibiotics in its 
lower reaches. Sulfamethoxazole, sulfapyridine, sulfameth-
azine and sulfamethizole were the compounds most fre-
quently detected, with maximum concentrations of 2482 
ng/l for sulfamethazine and 4297 ng/l for sulfamethoxa-
zole. However, median concentrations were <50 ng/l, ex-
cept for some outlying values at the sampling site near the 
mouth of the Llobregat River. 
Environmental risk posed by PhCs in 
effluent, surface water and drinking 
water
The risks posed by the occurrence of PhCs in water correlates 
with their potential adverse effects on aquatic organisms and 
are often evaluated by means of the risk quotient (RQ), a ra-
tio of the maximum measured (or predicted) concentration 
of a compound and its predicted no-effect concentration in 
water. In the Po Valley, Al Aukidy et al. [1] assessed the RQ 
using the secondary effluent and corresponding surface wa-
ter in two different case studies: (i) effluent from a large 
WWTP discharged into a receiving water body with a result-
ing dilution factor of 91, and (ii) effluent from a medium-
sized WWTP discharging into a small receiving water body, 
resulting in a dilution factor of 1. They found that sulfa-
methoxazole, clarithromycin and azithromycin had the high-
est high RQs and were, therefore, the most critical com-
pounds. In fact, according to the risk ranking system pro-
posed by Hernando et al. [13], these compounds pose a high 
environmental risk (RQ > 1): sulfamethoxazole and clarithro-
mycin in the two WWTP effluents investigated and in one re-
ceiving water body, and azithromycin in the effluent of one 
WWTP and its receiving canal B. Moreover, a medium risk 
(RQ in the range 0.1–1) was detected for sulfamethoxazole 
and clarithromycin in canal A, and azithromycin in effluent A.
According to Zuccato et al. [30], PhC concentrations mea-
sured in drinking water may give rise to human exposure in 
the ng /day range, corresponding to 3–4 orders of magnitude 
lower than those producing a pharmacological effect. Al-
though risk arising from acute exposure can therefore be re-
garded as unlikely, the possible effects of life-long exposures 
remain to be determined.
The predicted no-effect concentrations of effluents and 
sludge are not the only factors that need to be taken into ac-
count, as there is another source of risk: antibiotic-resistant 
bacteria (ARB) and genes coding for antbiotic resistance 
(ARG). The levels of ARG and ARB have been found to be sev-
eral orders of magnitude higher in raw WWTP influents than 
in treated effluents, but due to their high bacterial content, 
digested sludge also represents a significant route of environ-
mental contamination [21]. As reported in the literature, the 
percentage of antibiotics showing resistance is generally 
higher in treated wastewater effluent than in river water, but 
the latter increases downstream of a WWTP [14]. WWTPs 
can therefore play a vital role in the elimination or spread of 
ARB and ARG, as the treatment systems and their operational 
conditions are likely to influence their fate [24]. However, 
treated effluents with trace amounts of ARGs and ARBs dis-
charged into rivers or streams can undoubtedly add to envi-
ronmental contamination. In a comparison of release loads 
of ARGs and ARBs, Munir et al. [21] showed that the land 
application of biosolids from WWTPs is, by far, the greatest 
source of entry into the natural environment. Further re-
search is necessary to determine how to reduce the spread 
of these bacteria.
Best strategies for managing and treat-
ing hospital effluents (Case Study)
Hospital effluents are one of the main sources of PhCs re-
leased into the environment, not only because of the treat-
ments performed and pharmaceuticals administered and 
excreted within these facilities, but also due to the research 
and laboratory activities they house. Indeed, hospital efflu-
ents contain a wide spectrum of toxic substances, including 
medicines and their metabolites, chemicals, heavy metals, 
disinfectants sterilization agents, radioactive markers, and io-
dinated contrast agents used for diagnosis, which are gener-
ally present at concentrations of µg/l. According to a recent 
investigation carried out in Italy and elsewhere, these waste-
waters should be earmarked for special consideration. In 
fact, the concentrations of common PhCs in hospital efflu-
ents, including antibiotics, analgesics, anti-inflammatory 
drugs and iodinated contrast agents, are several orders of 
magnitude higher than in raw urban wastewater, as noted by 
Verlicchi et al. [32]. In legal terms, however, currently there is 
no distinction made between urban and hospital wastewa-
ters, and, despite their potentially hazardous loads, hospital 
effluent are generally discharged directly into the public sew-
age network and conveyed for co-treatment at the nearest 
municipal WWTP. In response to this problem, guidelines for 
the management and treatment of hospital effluents were 
recently drawn up by an Italian research group from the Uni-
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versity of Ferrara Department of Engineering [25,30], based 
on their experience of a purpose-built WWTP designed to 
treat the effluents from a new hospital complex (900 beds) in 
Ferrara, in addition to a small amount of urban wastewater. 
This plant has been in operation since July 2011 and consists 
of a multi-barrier system, including advanced biological treat-
ment (a membrane bioreactor), and advanced oxidation pro-
cesses (ozonation followed by UV irradiation) to enhance the 
removal of the different micro-pollutants by biological, 
chemical and physical means and to guarantee good separa-
tion between the solid and liquid phases. A schematic of the 
completed WWTP is shown in Fig. 8. 
Conclusions
Even if a treated effluent is discharged into a receiving body 
characterized by a high flow rate, PhC concentrations do not 
appear to be reduced to an acceptable environmental risk level. 
Hence, further measures are needed, including source control 
of the most critical compounds and enhancement of PhC re-
moval by appropriately upgrading existing WWTPs. In this re-
gard, although natural processes are often effective in remov-
ing many micro-pollutants, some effluent-derived contami-
nants seem to be resistant to biodegradation. These persistent 
polar pollutants require further study aimed at limiting the risks 
they pose to the environment and to human healt.
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